Institut Bordet - Retour à la page d'accueil
en
I want to donate to research

Francesco Sclafani

Department : Medical oncology
 
francesco.sclafani [at] bordet.be

Publications

MEK and PD-L1 inhibition in colorectal cancer: a burning blaze turning into a flash in the pan.

Authors : Sclafani F
Year : 2019
Journal : Lancet Oncol

Editorial: Adjuvant chemotherapy for rectal cancer: playing the devil's advocate.

Authors : Sclafani F, Hendlisz A
Year : 2019
Journal : Curr Opin Oncol

PD-1 and PD-L1 inhibitors in oesophago-gastric cancers.

Authors : Akin Telli T, Bregni G, Camera S, Deleporte A, Hendlisz A, Sclafani F
Year : 2019
Journal : Cancer Lett

New therapeutic targets in pancreatic cancer.

Authors : Lai E, Puzzoni M, Ziranu P, Pretta A, Impera V, Mariani S, Liscia N, Soro P, Musio F, Persano M, Donisi C, Tolu S, Balconi F, Pireddu A, Demurtas L, Pusceddu V, Camera S, Sclafani F, Scartozzi M
Year : 2019
Journal : Cancer Treat Rev

Grey areas and evidence gaps in the management of rectal cancer as revealed by comparing recommendations from clinical guidelines.

Authors : Bregni G, Akin Telli T, Camera S, Baratelli C, Shaza L, Deleporte A, Moretti L, Bali MA, Liberale G, Hendlisz A, Sclafani F
Year : 2019
Journal : Cancer Treat Rev

More publications »

Follow us!

Youtube

Exclusive images of the new Jules Bordet Institute!

Watch the video and discover the major project for the new Jules Bordet Institute. Magnificent images of the construction work on the   80,000 m² dedicated exclusively to cancer are accompanied by explanations on how the project was conceived to combine excellence of patient care with optimal well-being for patients and care staff.